D3-binding molecules and uses thereof
US-2024376194-A1 · Nov 14, 2024 · US
US9816994B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9816994-B2 |
| Application number | US-201615161170-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 20, 2016 |
| Priority date | Jun 20, 2012 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a treatment method for damaging an erythrocyte and a leukocyte while suppressing damage to cells other than blood cells present in blood. In an embodiment, the disclosure relates to a method for treating a sample containing blood components, the method including mixing a sample containing blood components with a surfactant A, where the surfactant A is a nonionic surfactant represented by General formula R 1 —O—(EO)n-R 2 (I).
Opening claim text (preview).
What is claimed is: 1. A method for separating or detecting a tumor cell and/or a cancer cell in a sample containing blood components, the method comprising treating the sample by mixing the sample with a liquid containing a surfactant A, wherein no fixation agent is used, and the surfactant A is a nonionic surfactant represented by formula (I) R 1 —O-(EO) n -R 2 (I) wherein: R 1 is a hydrocarbon group having a branched chain and having a carbon number in the range of 12 to 40, EO is an oxyethylene group, n is an average addition mole number of EO in the range of 23 to 50, and R 2 is a hydrogen atom or a hydrocarbon group having a carbon number in the range of 1 to 3, wherein the method eliminates erythrocytes and leukocytes present in the sample while suppressing damage to the tumor cell and/or the cancer cell. 2. The method according to claim 1 , wherein the surfactant A is a polyoxyethylene alkylene ether with an EO in a range of 23 to 35. 3. The method according to claim 1 , wherein the liquid containing the surfactant A satisfies a blood cell elimination effect as described in (1) below: (1) preparing a control sample by diluting a predetermined amount of blood with distilled water so that an absorbance value measured by absorption photometry using a micro-plate reader and light of a wavelength of not less than 600 nm is not less than 1 and is less than 2; and preparing a test sample from a liquid containing 2.5 to 5 w/v % of the surfactant A, so that the time for the absorbance value of the test sample measured by absorption photometry by light having a wavelength of not less than 600 nm to be decreased to half of the absorbance value of the control sample is not more than one hour.
for cancer · CPC title
Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00}) · CPC title
Partitioning blood components · CPC title
Physics · mapped topic
from cyclic ethers and other compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.